Krishna Murthi Email & Phone Number

California, United States

South San Francisco, California, Us

Foster City, Ca, Us

Lead strategic alliances in oncology, inflammation and virology across Research, Clinical Development, Manufacturing, Supply Chain and Commercialization areas

Foster City, Ca, Us

A life sciences consulting firm focused on developing growth strategies for Fortune 500 Pharma/Biotech/Life Science, Medical Device, Medical Diagnostics, Health IT and consumer OTC drug companies• Managed a portfolio of business client relationships and built new book of business o Established and managed relationships with executive leadership, GMs, CSOs, strategy, marketing and R&D heads at Fortune 500 Pharma/Biotech, Medical Device/Diagnostics, Health IT verticals• Developed US and OUS growth strategy and associated tactics for over 20 engagements: o New market (white space), market adjacency assessments o TPP development and refinement o Value proposition definition and refinement o Portfolio, pricing and customer engagement strategies o M&A due diligence

A pharmaceutical consulting company providing integrated R&D and commercialization solutions to academic and biotech/pharma companiesEstablished and managed relationships with clients from academia, biotech/pharma for consulting involving business development and commercial opportunity assessments

An angel investor funded biotech company focused on antibacterial and oncology drug discovery.• Built and remotely led (from Boston, MA), a fully functional off-shore R&D unit in India• Managed a team of 30 scientific (medicinal/computational chemistry, biology, DMPK), business and operations personnel • Conducted scientific/business due diligence on multiple licensing opportunities• Pitched company to venture capital firms and private investors for Series A financing

Martinsried, De

A publicly traded (NASDAQ and TecDax) oncology focused biotech company with ~300 employees formed in 2000 after a merger with Mitotix. It had units in Munich, Germany, Waltham, MA and Princeton, NJ.• Led US drug discovery efforts as Director in oncology and infectious diseases• Managed teams of 15-20 chemists• Advanced oncology kinase inhibitors RGB-286638 and RGB-344064 from early leads to IND stage• Led GPC Biotech’s $60 million alliance with Altana Pharma, successfully achieved $5M in milestone payments

Martinsried, De

A publicly traded (NASDAQ and TecDax) oncology focused biotech company formed in 2000 after a merger with Mitotix Inc. It had sites in Munich, Germany, Waltham, MA and Princeton, NJ• Led multiple lead identification and lead optimization projects in oncology • Pioneered the use of outsourced chemistry to supplement internal R&D efforts, managed multiple global drug discovery CROs in India, UK, Hungaryo Scientific lead on BD licensing team

Martinsried, De

A venture funded biotechnology company focused on targeted oncology, anti-fungal therapies• Engaged in lead identification/optimization efforts in the oncology and anti-fungal therapeutic areas• Managed the DuPont Merck kinase inhibitor strategic partnership

Mba

Post-Doctoral Research Associate With Professor Richard Sundberg, Heterocyclic Chemistry

Post-Doctoral Research Associate With Professor Robert Holton, Synthetic Organic Chemistry

Ph.D., Organic Chemistry